Huntington's disease (HD) causes severe motor impairments that are characterized by chorea, dystonia, and impaired fine motor control. The motor deficits include deficits in the control of the forelimb, but as yet there has been no comprehensive assessment of the impairments in arm, hand and digit movements as they are used in every-day tasks. The present study investigated the reaching of twelve HD subjects and twelve agematched control subjects on a reach-to-eat task. The subjects were asked to reach for a small food item, with the left or the right hand, and then bring it to the mouth for eating. The task assesses the major features of skilled forelimb use, including orienting to a target, transport of the hand to a target, use of a precision grasp of the target, limb withdrawal to the mouth, and release of the food item into the mouth, and the integration of the movements into a smooth act. The movements were analyzed frame-by-frame by scoring the video record using an established movement element rating scale and by biometric analysis to describe limb trajectory. All HD subjects displayed greater reliance on more proximal movements in reaching. They also displayed overall jerkiness, a significant impairment in end point error correction (i.e. no smooth trajectories), deficits in timing and terminating motion (overshooting the target), impairments in rotation of the hand, abnormalities in grasping, and impairments in releasing the food item to the mouth. Although impairment in the control of the distal segments of the limb was common to all subjects, the intrusion of choreatic movements produced a pattern of highly variable performance between subjects. The quantification of reaching performance as measured by this analysis provides new insights into the impairments of HD subjects, allows an easily administered and inexpensive way to document the many skilled limb movement abnormalities, and relates the impairments to a real-world context. The protocol can serve as a useful clinical tool to evaluate innovative therapeutic interventions in HD such as physiotherapy, drug therapy, or functional neurosurgical procedures.
Introduction
Huntington's disease (HD) is a neurodegenerative, genetic disorder resulting in cognitive and psychiatric deficits, as well as abnormal movements (Myrianthopoulos, 1966; Pearson and Petersen, 1954) . The impairments in movement are characterized by chorea, dystonia, and impaired fine motor control. The pathology typically starts in the caudate and putamen (striatum), selectively affecting the enkephalincontaining GABAergic medium spiny neurons (MSN; Albin et al., 1990; Albin et al., 1991) . Cortical areas, however, display anatomical changes early during HD as well (Hobbs et al., 2010; Rosas et al., 2006) . The MSNs are part of the basal ganglia's indirect pathway and this cell loss (i.e. loss of GABA) results in disinhibition of the thalamus. In turn, disinhibition is thought to contribute to choreatic symptoms (Penney and Young, 1983) . In its later stages, the disease spreads to other parts of the brain, including the direct pathway of the basal ganglia and cortical areas that are part of the cortico-striatal circuits involved in the planning and execution of voluntary and goal-directed movement. Although there have been significant advances in diagnosing HD (e.g. genetic testing), there is still a need for standardized tests that can be used in both the clinic and laboratory to document the motor impairments caused by the disease and document the effects of treatments on those impairments.
Motor impairments of HD have been studied in laboratory-based tasks, and include deficits in the control of the arm and hand. There are a number of alterations to arm movement including temporal features (i.e. time-to-peak acceleration, velocity, and de-acceleration), movement termination, and accuracy in grasping a target (Agostino et al., 1992; Bonfiglioli et al., 1998; Fellows et al., 1997; Smith et al., Neurobiology of Disease 41 (2011) 560-569 
